Single dose oral lumiracoxib for postoperative pain in adults

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 7, 2010, Pages 1-25

  Roy, Yvonne M ^a   Derry, Sheena ^b   Moore, R Andrew ^b  

^a Pain Research Unit ^*  (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; IBUPROFEN; LUMIRACOXIB; NAPROXEN; PLACEBO; ROFECOXIB;

ANALGESIA; ARTHROPLASTY; ARTICLE; DENTAL SURGERY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; PAIN ASSESSMENT; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 84904684531     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006865.pub2     Document Type: Article

References (48)

1. Chan VWS, Clark A J, Davis JC, Wolf RS, Kellstein D, Jayawardene S. The post-operative analgesic efficacy and tolerability of lumiracoxib compared with placebo and naproxen after total knee or hip arthroplasty. Acta Anaesthesiologica Scandinavica 2005;Nov 49(10):1491-500.
2. Fricke J, Davis N, Yu V, Krammer G. Lumiracoxib 400mg compared with celecoxib 400 mg and placebo for treating pain following dental surgery: a randomized, controlled trial. Journal of Pain 2008;9(1):20-7. [DOI: 10.1016/ j.jpain.2007.08.004]
3. Kellstein D, Ott D, Jayawardene S, Fricke J. Analgesic efficacy of a single dose of lumiracoxib compared with rofecoxib, celecoxib and placebo in the treatment of postoperative dental pain. International Journal of Clinical Practice 2004;58(3):244-50.
4. Zelenakas K, Fricke JR Jr, Jayawardene S, Kellstein D. Analgesic efficacy of single oral doses of lumiracoxib and ibuprofen in patients with postoperative dental pain. International Journal of Clinical Practice 2004;58(3):251-6.
5. Bitner M, Katterhorn J, Hatfield C, Gao J, Kellstein D. Efficacy and tolerability of lumiracoxib in the treatment of primary dysmenorrhoea. International Journal Clinical Practice 2004;58(4):340-5.
6. Schnitzer TJ, Beier J, Geusens P, Hasler P, Patel SK, Senftleber I, et al. Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: A phase II, four week, multicenter randomised, double blind, placebo-controlled trial. Arthritis and Rheumatism 2004;51(4):549-57.
7. Bannworth B, Berenbaum F. Clinical pharmacology of lumiracoxib, a second generation cyclooxygenase 2 selective inhibitor. Expert Opinion on Investigational Drugs 2005;14 (4):521-33.
8. Barden J, Edwards JE, McQuay HJ, Moore RA. Pain and analgesic response after third molar extraction and other postsurgical pain. Pain 2004;107:86-90.
9. Barden J, Derry S, McQuay HJ, Moore RA. Bias from industry trial funding? A framework, a suggested approach, and a negative result. Pain 2006;121(3):207-18. [DOI: 10.1016/j.pain.2005.12.011]
10. Clarke R, Derry S, Moore RA, McQuay HJ. Single dose oral etoricoxib for postoperative pain. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/ 14651858.CD004309.pub2]
11. Collins SL, Edwards J, Moore RA, Smith LA, McQuay HJ. Seeking a simple measure of analgesia for mega-trials: is a single global assessment good enough?. Pain 2001;91((1- 2)):189-94.
12. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 310:452-4.
13. Cooper SA. Single-dose analgesic studies: the upside and downside of assay sensitivity. In: Max MB, Portenoy RK, Laska EM editor(s). The design of analgesic clinical trials. Advances in Pain Research and Therapy. Vol. 18, New York: Raven Press, 1991:117-24.
14. Day RO, McLachlan AJ, Graham GG, Williams KM. Pharmokinetics of non-steroidal anti-inflammatory drugs in synovial fluid. Baillieres Clinical Rheumatology 1988;2: 363-93.
15. Derry S, Barden J, McQuay HJ, Moore RA. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD004233.pub2]
16. Derry C, Derry S,Moore RA, McQuay HJ. Single dose oral naproxen and naproxen sodium for acute postoperative pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD004234.pub2]
17. Derry C, Derry S,Moore RA, McQuay HJ. Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD001548]
18. Derry P, Derry S, Moore RA, McQuay HJ. Single dose oral diclofenac for acute postoperative pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD004768.pub2]
19. FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. New England Journal of Medicine 2001;345(6):433-42.
20. Forrest JB, Camu F, Greer IA, Kehlet H, Abdalla M, Bonnet F. Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. British Journal of Anaesthesia 2002;88(2):227-33.
21. Garner S, Fidan D, Frankish R, Judd M, Towheed T, Wells G, Tugwell P. Rofecoxib for the treatment of rheumatoid arthritis. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD003685.pub2]
22. Grahame-Smith DG, Aronson JK. Oxford textbook of clinical pharmacology and drug therapy. 3rd Edition. Oxford: Oxford University Press, 2002.
23. Hawkey CJ. Cox-2 inhibitors. Lancet 1999;353(9149): 307-14.
24. Hawkey CJ. Gastrointestinal safety of COX-2 specific inhibitors. Gastroenterology Clinics of North America 2001; 30(4):921-36.
25. Hawkey CJ. NSAIDs, coxibs, and the intestine. Journal of Cardiovascular Pharmacology 2006;47(Suppl 1):S72-5.
26. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
27. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006;332:1302-08.
28. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Annals of Internal Medicine 1987;107: 224-33.
29. Lloyd R, Derry S, Moore RA, McQuay HJ. Intravenous parecoxib for acute postoperative pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD004771.pub4]
30. McQuay HJ, Moore RA. Placebo. Postgraduate Medical Journal 2005;81:155-60. [DOI: 10.1136/ pgmj.2004.024737]
31. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999; 354:1896-900.
32. Moore A, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics. Pain 1996;66(2-3):229-37.
33. Moore A, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: Verification from independent data. Pain 1997;69(1-2):127-30.
34. Moore A, Moore O, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: Use of pain intensity and visual analogue scales. Pain 1997;69(3): 311-5.
35. Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ. Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3): 209-16.
36. Moore RA, Edwards J, Barden J, McQuay HJ. Bandolier's Little Book of Pain. Oxford: Oxford University Press, 2003. [ISBN: 0-19-263247-7]
37. Moore RA, Edwards JE, McQuay HJM. Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results. Pain 2005;116:322-31.
38. Moore RA, Derry S, Makinson GT, McQuay HJ. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports. Arthritis Research and Therapeutics 2005;7(3): R644-65.
39. Moore A, McQuay H. Bandolier's Little Book of Making Sense of the Medical Evidence. Oxford: Oxford University Press, 2006. [ISBN: 0-19-856604-2]
40. Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15-24. [ISBN: 978-0-931092-69-5]
41. Morris JA, Gardner MJ. Calculating confidence intervals for relative risk, odds ratio and standardised ratios and rates. In: Gardner MJ, Altman DG editor(s). Statistics with confidence - confidence intervals and statistical guidelines. London: BMJ, 1995:50-63.
42. Mysler E. Lumiracoxib (Prexige): a new selective COX-2 inhibitor. International Journal of Clinical Practice 2004;58 (6):606-11.
43. Patrono C, Baigent C. Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges. Molecular Interventions 2009;9(1):31-9. [DOI: 10.1124/mi.9.1.8]
44. Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 2004;364(9435):665-74.
45. Toms L, McQuay HJ, Derry S, Moore RA. Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD004602]
46. Toms L, Derry S, Moore RA, McQuay HJ. Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/ 14651858.CD001547.pub2]
47. Tramèr MR, Reynolds DJM, Moore RA, McQuay HJ. Impact of covert duplicate results on meta-analysis: a case study. BMJ 1997;315:635-9.
48. Roy YM, Derry S, Moore RA. Single dose oral lumiracoxib for postoperative pain. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/ 14651858.CD006865]